Poly (ADP-Ribose) Polymerase 1 Mediated Arginase II Activation Is Responsible for Oxidized LDL-Induced Endothelial Dysfunction

about

Poly (ADP-Ribose) Polymerase 1 Mediated Arginase II Activation Is Responsible for Oxidized LDL-Induced Endothelial Dysfunction

Item

http://www.wikidata.org/entity/Q58777359

description

article

@en

im Januar 2018 veröffentlichter wissenschaftlicher Artikel

@de

наукова стаття, опублікована у 2018

@uk

name

Poly (ADP-Ribose) Polymerase 1 ...... nduced Endothelial Dysfunction

@en

type

Item

label

Poly (ADP-Ribose) Polymerase 1 ...... nduced Endothelial Dysfunction

@en

prefLabel

Poly (ADP-Ribose) Polymerase 1 ...... nduced Endothelial Dysfunction

@en

P1476

Poly (ADP-Ribose) Polymerase 1 ...... nduced Endothelial Dysfunction

@en

P2093

Aihua Wang

http://www.w3.org/2001/XMLSchema#string

Bin Liu

http://www.w3.org/2001/XMLSchema#string

Mingxiang Zhang

http://www.w3.org/2001/XMLSchema#string

Qi Wang

http://www.w3.org/2001/XMLSchema#string

Qinghua Lu

http://www.w3.org/2001/XMLSchema#string

Tong Zhao

http://www.w3.org/2001/XMLSchema#string

Wei Zhang

http://www.w3.org/2001/XMLSchema#string

Wen Qiao

http://www.w3.org/2001/XMLSchema#string

Wenbin Yu

http://www.w3.org/2001/XMLSchema#string

Zhaoyang Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Effect of 27nt small RNA on endothelial nitric-oxide synthase expression

Poly(ADP-ribose) polymerase binds with transcription enhancer factor 1 to MCAT1 elements to regulate muscle-specific transcription

A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR/ABL-associated leukemia

Information-driven protein-DNA docking using HADDOCK: it is a matter of flexibility.

Protective effects of PARP-1 knockout on dyslipidemia-induced autonomic and vascular dysfunction in ApoE mice: effects on eNOS and oxidative stress.

Myosin light chain kinase in microvascular endothelial barrier function.

Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): a critical player in the development of atherosclerosis and related disorders.

Molecular functions of nuclear actin in transcription.

Role of poly(ADP-ribose) polymerase 1 (PARP-1) in cardiovascular diseases: the therapeutic potential of PARP inhibitors

A new, potent poly(ADP-ribose) polymerase inhibitor improves cardiac and vascular dysfunction associated with advanced aging

P304

882

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FPHAR.2018.00882

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

30158868

http://www.w3.org/2001/XMLSchema#string

P921

Farmakologi

P932

6104189

http://www.w3.org/2001/XMLSchema#string